GHRS
GH Research PLC
There isn't enough reported data to score GHRS yet.
GHRS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
GHRS's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
GHRS PE Valuation
GHRS has no meaningful PE right now: it lost money over the past year.
GHRS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect GHRS's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
GHRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.00 | -$0.26 |
| Q1 2026 | -$0.92 | -$0.13 |
| Q4 2025 | -$0.80 | -$0.05 |
| Q3 2025 | -$0.74 | +$0.06 |
| Q2 2025 | -$0.74 | -$0.06 |
| Q1 2025 | -$0.79 | -$0.16 |
| Q4 2024 | -$0.75 | -$0.04 |
| Q3 2024 | -$0.80 | +$0.01 |
GHRS lost $1.00 per share over the past year, a bigger loss than the year before.
GHRS Quarterly Revenue
GHRS's revenue is shrinking: $0 last quarter.
GHRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15M | -$6M |
| Q1 2026 | -$10.7M | -$2.2M |
| Q4 2025 | -$12.3M | -$1.8M |
| Q3 2025 | -$14.5M | -$2.2M |
| Q2 2025 | -$9M | +$918K |
| Q1 2025 | -$8.6M | +$1M |
| Q4 2024 | -$10.5M | -$2.4M |
| Q3 2024 | -$12.3M | -$2M |
GHRS has burned cash in almost every quarter: −$53M over the past year, against −$40M the year before.
GHRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.3% | +4.5M shares |
| 1 year | +7.3% | +4.5M shares |
| 3 years | +28% | +14.5M shares |
| 5 years | +36% | +17.7M shares |
| Available history | +138% | +38.5M shares |
GHRS has 67M diluted shares, up 7.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
GHRS hasn't bought back shares in the past year.
GHRS Net Leverage
GHRS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GHRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.8 | Neutral |
| Stochastic | 12.9 | Oversold |
GHRS's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
GHRS PE vs Healthcare Sector
GHRS has no meaningful PE right now: it lost money over the past year.
GHRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.3 | 8.7% below |
| 20 week MA | $25.0 | 26% below |
| 50 week MA | $20.4 | 9.4% below |
| 100 week MA | $16.3 | 14% above |
| 200 week MA | $12.9 | 43% above |
GHRS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 43% above its 200-week average.
GHRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.3 | $23.7 | +23% |
| 2022 | $23.7 | $9.75 | -59% |
| 2023 | $9.75 | $5.80 | -41% |
| 2024 | $5.80 | $7.12 | +23% |
| 2025 | $7.12 | $12.6 | +77% |
| 2026 YTD | $12.6 | $18.5 | +47% |
GHRS has finished higher in three of the last five years. It's up 47% so far in 2026.